• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Ecchymosis (1818)
Event Date 10/08/2019
Event Type  Injury  
Manufacturer Narrative
Since the device was not returned, we are unable to perform further root cause analysis and the exact cause of the reported event is unknown.All devices are 100% tested and all products are 100% inspected for damages and irregularities during manufacture.Hemorrhage is a known inherent risk of endovascular procedure and are documented in our device¿s instruction for use (ifu).Based on the reported information, there is no evidence suggesting that the device was defective, but rather a post procedure related event.If information is provided in the future, a supplemental report will be issued.
 
Event Description
González a, ortega-quintanilla j, zapata-arriaza e, et al.Dose adjustment of clopidogrel in hyper-responder patients with unruptured intracranial aneurysms treated with stents.Journal of neurointerventional surgery.2020;12(5):499-504.Doi:10.1136/neurintsurg-2019-015288.20 patients with 24 unruptured intracranial aneurysms were identified as clopidogrel hyper-responders (pru =80).Mean age was 54.6 years (range 42¿74) and 85% were women.Patient #4 was treated with 2 pipeline devices and was reported to have post procedure reproductive system bleeding.The aneurysm was reported to have occluded.Patient #11 was reported to have stenosis intrastent at 12 months and the aneurysm was occluded.Patient #15 was reported to have experienced atraumatic ankle hematoma and the aneurysm was occluded.Patient #17 experienced epistaxis post the procedure and the aneurysm was occluded.One of the patients (after 5 days of treatment) required medical treatment with a blood transfusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
7635140379
MDR Report Key10340032
MDR Text Key205100943
Report Number2029214-2020-00746
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 07/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/29/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/21/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-